60727Toplam
0Olumlu
0Olumsuz
50Nötr
Piyasa:
Tümü
🇹🇷 BIST
Kripto
🇺🇸 ABD
🇰🇿 KASE
🇪🇬 EGX
🇸🇾 DSE
🇸🇦 Tadawul
🇦🇪 DFM
🇶🇦 QSE
🇷🇺 MOEX
🇬🇧 LSE
🇩🇪 Xetra
🇪🇺 Euronext
🇸🇪 Nordic
🇲🇦 CSE
🇯🇴 ASE
BRVM
🇮🇳 India
🇭🇰 HKEX
🇰🇷 KRX
🇿🇦 JSE
🇦🇺 ASX
🇧🇷 B3
🇹🇼 TWSE
🇸🇬 SGX
🇨🇳 China
🇯🇵 Japan
Sayfa 671 / 1215 · toplam 60727 haber
—
Ranpak Q1 2026 loss narrows as automation boosts top line
Bu özet yapay zekâ ile otomatik üretildi
Ranpak Q1 2026 loss narrows as automation boosts top line
—
Hitting the ‘GenAI wall’: Where generative AI stops working, and what it means for your talent strategy
Bu özet yapay zekâ ile otomatik üretildi
Hitting the ‘GenAI wall’: Where generative AI stops working, and what it means for your talent strategy
—
How CVS Uses Robots to Keep Your Deodorant in Stock
Bu özet yapay zekâ ile otomatik üretildi
How CVS Uses Robots to Keep Your Deodorant in Stock
—
How Private-Credit Funds Keep Debt Off Their Balance Sheets
Bu özet yapay zekâ ile otomatik üretildi
How Private-Credit Funds Keep Debt Off Their Balance Sheets
—
Is Autolus Therapeutics (AUTL) One of the Best Biotech Penny Stocks to Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Is Autolus Therapeutics (AUTL) One of the Best Biotech Penny Stocks to Buy in 2026?
—
Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene Therapy
Bu özet yapay zekâ ile otomatik üretildi
Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene Therapy
—
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel
Bu özet yapay zekâ ile otomatik üretildi
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel
—
Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026
Bu özet yapay zekâ ile otomatik üretildi
Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026
—
Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851
Bu özet yapay zekâ ile otomatik üretildi
Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851
—
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock
Bu özet yapay zekâ ile otomatik üretildi
Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock
—
Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026
Bu özet yapay zekâ ile otomatik üretildi
Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026
—
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
Bu özet yapay zekâ ile otomatik üretildi
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
—
Why Rezolve AI (RZLV) Is Expanding Its Commerce AI Platform Through Microsoft Foundry
Bu özet yapay zekâ ile otomatik üretildi
Why Rezolve AI (RZLV) Is Expanding Its Commerce AI Platform Through Microsoft Foundry
—
Why Aeva Technologies (AEVA) Is Expanding Its AI-Powered Smart Infrastructure Deployment
Bu özet yapay zekâ ile otomatik üretildi
Why Aeva Technologies (AEVA) Is Expanding Its AI-Powered Smart Infrastructure Deployment
—
Why Palantir (PLTR) Is Expanding Its AI Software Footprint at the USDA
Bu özet yapay zekâ ile otomatik üretildi
Why Palantir (PLTR) Is Expanding Its AI Software Footprint at the USDA
—
Why Applied Digital (APLD) Is Scaling Its AI Factory Backlog With a New Hyperscaler Lease
Bu özet yapay zekâ ile otomatik üretildi
Why Applied Digital (APLD) Is Scaling Its AI Factory Backlog With a New Hyperscaler Lease
—
Why Gorilla Technology (GRRR) Is Deepening Its AI Infrastructure Push With Astrikos.AI
Bu özet yapay zekâ ile otomatik üretildi
Why Gorilla Technology (GRRR) Is Deepening Its AI Infrastructure Push With Astrikos.AI
—
Gold is going to hit $8,000 by 2031, Deutsche Bank predicts. Why the world is distracted by this precious metal now
Bu özet yapay zekâ ile otomatik üretildi
Gold is going to hit $8,000 by 2031, Deutsche Bank predicts. Why the world is distracted by this precious metal now
—
Global shares steady as yen intervention keeps currency markets in focus - Reuters
Bu özet yapay zekâ ile otomatik üretildi
Global shares steady as yen intervention keeps currency markets in focus Reuters
—
The U.S. economy is booming — just not where 50 million Americans live
Bu özet yapay zekâ ile otomatik üretildi
The U.S. economy is booming — just not where 50 million Americans live
—
CFOs On the Move: Week ending May 1
Bu özet yapay zekâ ile otomatik üretildi
CFOs On the Move: Week ending May 1
—
48% of retirees can't sustain their lifestyle — and Kevin Warsh's expected Fed rate cut could make it worse
Bu özet yapay zekâ ile otomatik üretildi
48% of retirees can't sustain their lifestyle — and Kevin Warsh's expected Fed rate cut could make it worse
—
Blue Moon Metals Inc. (BMM) Announces Consolidation of Springer Tungsten Claims Through Acquisition of Claims from GoldPlay LLC and a Private Party
Bu özet yapay zekâ ile otomatik üretildi
Blue Moon Metals Inc. (BMM) Announces Consolidation of Springer Tungsten Claims Through Acquisition of Claims from GoldPlay LLC and a Private Party
—
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT
Bu özet yapay zekâ ile otomatik üretildi
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT
—
Citizens Initiates Coverage of Opus Genetics (IRD)
Bu özet yapay zekâ ile otomatik üretildi
Citizens Initiates Coverage of Opus Genetics (IRD)
—
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
Bu özet yapay zekâ ile otomatik üretildi
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
—
Why Climb Bio (CLYM) is One of the Best Performing Small Cap Stocks So Far in 2026
Bu özet yapay zekâ ile otomatik üretildi
Why Climb Bio (CLYM) is One of the Best Performing Small Cap Stocks So Far in 2026
—
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program
Bu özet yapay zekâ ile otomatik üretildi
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program
—
Is Tronox Holdings plc (TROX) One of the Best Performing Small Cap Stocks So Far in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Is Tronox Holdings plc (TROX) One of the Best Performing Small Cap Stocks So Far in 2026?
—
Canaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 Results
Bu özet yapay zekâ ile otomatik üretildi
Canaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 Results
—
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech
Bu özet yapay zekâ ile otomatik üretildi
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech
—
Why GE HealthCare Technologies (GEHC) is One of the Best Medical Device Stocks to Invest in Right Now
Bu özet yapay zekâ ile otomatik üretildi
Why GE HealthCare Technologies (GEHC) is One of the Best Medical Device Stocks to Invest in Right Now
—
Medtronic plc (MDT) Receives the CE Mark for the Stealth AXiS™ Surgical System
Bu özet yapay zekâ ile otomatik üretildi
Medtronic plc (MDT) Receives the CE Mark for the Stealth AXiS™ Surgical System
—
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
Bu özet yapay zekâ ile otomatik üretildi
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
—
Truist Cuts PT on Stryker Corporation (SYK) as Part of Fiscal Q1 Results Preview in MedTech
Bu özet yapay zekâ ile otomatik üretildi
Truist Cuts PT on Stryker Corporation (SYK) as Part of Fiscal Q1 Results Preview in MedTech
—
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
Bu özet yapay zekâ ile otomatik üretildi
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
—
Is Boston Scientific Corporation (BSX) One of the Best Medical Device Stocks to Invest in Right Now?
Bu özet yapay zekâ ile otomatik üretildi
Is Boston Scientific Corporation (BSX) One of the Best Medical Device Stocks to Invest in Right Now?
—
Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results
Bu özet yapay zekâ ile otomatik üretildi
Kiniksa Pharmaceuticals International (KNSA) Announces Q1 2026 Financial Results
—
RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech
Bu özet yapay zekâ ile otomatik üretildi
RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech
—
Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study
Bu özet yapay zekâ ile otomatik üretildi
Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst® Adult Study
—
Zoetis Inc. (ZTS) Announces Expansion of Capabilities of Vetscan OptiCell
Bu özet yapay zekâ ile otomatik üretildi
Zoetis Inc. (ZTS) Announces Expansion of Capabilities of Vetscan OptiCell
—
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?
Bu özet yapay zekâ ile otomatik üretildi
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts?
—
Why Eli Lilly and Company (LLY) is One of the Best Drug Stocks to Buy According to Analysts
Bu özet yapay zekâ ile otomatik üretildi
Why Eli Lilly and Company (LLY) is One of the Best Drug Stocks to Buy According to Analysts
—
Crypto Card Spending Jumps 500%— Here's What's Driving It
Bu özet yapay zekâ ile otomatik üretildi
Crypto Card Spending Jumps 500%— Here's What's Driving It
—
DTE sees up to 8.4 GW data center opportunity
Bu özet yapay zekâ ile otomatik üretildi
DTE sees up to 8.4 GW data center opportunity
—
Bio-Rad Laboratories Q1 Earnings Call Highlights
Bu özet yapay zekâ ile otomatik üretildi
Bio-Rad Laboratories Q1 Earnings Call Highlights
—
Butterfly Network Q1 Earnings Call Highlights
Bu özet yapay zekâ ile otomatik üretildi
Butterfly Network Q1 Earnings Call Highlights
—
ATI Q1 Earnings Call Highlights
Bu özet yapay zekâ ile otomatik üretildi
ATI Q1 Earnings Call Highlights
—
The Best Way to Invest With Bill Ackman. Hint: The IPO Wasn’t Pretty.
Bu özet yapay zekâ ile otomatik üretildi
The Best Way to Invest With Bill Ackman. Hint: The IPO Wasn’t Pretty.
—
Why Are Investors Ebullient About Equities but Dour Over Dividends?
Bu özet yapay zekâ ile otomatik üretildi
Why Are Investors Ebullient About Equities but Dour Over Dividends?
Sayfa 671 / 1215 · toplam 60727 haber